Hims & Hers Health, Inc.

Fundamentals6.0
Price Action4.0
News Sentiment4.0
AI Rating
5.0

Key Drivers

  • Cash flow strength
  • Margin compression
  • Rising leverage

AI
AI Summary

5.0

HIMS is now a transition story rather than a pure growth story: revenue guidance and positive free cash flow still support the thesis, but the sharp gross-margin decline, negative EBITDA, and ongoing legal/regulatory overhang mean the stock likely needs clear proof of margin recovery and compliant execution before the multiple can re-rate.

MarginCompression
RegulatoryRisk
FreeCashFlow‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Cash flow strength
  • Margin compression
  • Rising leverage

HIMS finished FY2025 with strong growth, healthy margins and cash generation, but Q1 2026 showed margin compression, a net loss, and higher leverage, making sustained free cash flow and margin recovery the key watchpoints.

FreeCashFlow
MarginPressure

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Support Holding
  • Momentum Fading
  • Reclaim Needed

HIMS remains technically cautious as the post-rally pullback held near $24-$24.5 support, but the stock must reclaim the high-$20s/$29-$31 resistance zone to restore bullish momentum.

pullback
Support Level: $24.00-$24.50
Resistance Level: $29.00-$31.00

Sharp rally into 2026-05-11 quickly reversed, suggesting weakening momentum and profit-taking

Sentiment & News

4.0

Key News Insights:

  • Revenue miss
  • Margin pressure
  • Guidance raised

HIMS posted mixed Q1 2026 results with revenue growth but a notable miss and margin pressure from its GLP-1 strategy shift, sending the stock sharply lower even as management raised full-year revenue guidance and expects second-half margin improvement.

earnings
volatility

The update is likely near-term bearish for HIMS shares due to weaker profitability and the sharp selloff, though the improved full-year outlook could help offset sentiment if execution improves